Category: Life Sciences
Life Sciences market research reports by DelveInsight
-
TCR Therapy- Pipeline Insight, 2025
DelveInsight’s, “TCR Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in TCR Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessm ... Read More
-
Glioma - Pipeline Insight, 2025
DelveInsight’s, “Glioma - Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More
-
Postmenopausal Osteoporosis - Pipeline Insight, 2025
DelveInsight’s, “Postmenopausal Osteoporosis - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Postmenopausal Osteoporosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also ... Read More
-
AXL Inhibitors - Pipeline Insight, 2025
DelveInsight’s, “AXL Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 16+ companies and 20+ pipeline drugs in AXL Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025
“Ubiquitin Specific Proteases (USP) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Ubiquitin Specific Proteases (USP) Inhibitor development. The report provides detailed co ... Read More
-
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The total market size in the 7MM for multiple myeloma was estimated to be nearly USD 21,300 million in 2023, which is expected to show positive growth by 2034, owing to rise in incident cases, label expansion and penetration of current therapies in earlier lines, high adoption of newe ... Read More
-
IgG4-Related Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights IgG4-RD can affect virtually any organ, with common presentations including the pancreas, bile ducts, salivary glands, lacrimal glands, orbits, kidneys, lungs, and retroperitoneum. The true prevalence of IgG4-RD is unknown. Given its relatively recent discovery, lack of widespread rec ... Read More
-
Liver Cirrhosis - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The Liver Cirrhosis market size in the 7MM was nearly USD 3,100 million in 2023, which is further anticipated to increase with a siginificant CAGR during the forecast period from (2024-2034). Liver cirrhosis is a chronic and progressive liver disease characterized by the replacement o ... Read More
-
TIM-3 Antagonist - Pipeline Insight, 2025
“TIM-3 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across TIM-3 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Selective COX-2 Inhibitor - Pipeline Insight, 2025
“Selective COX-2 Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Selective COX-2 Inhibitor development. The report provides detailed coverage of the pipeline landscape for t ... Read More
-
Growth Hormone (GH) Agonist - Pipeline Insight, 2025
“Growth Hormone (GH) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Growth Hormone (GH) Agonist development. The report provides detailed coverage of the pipeline landscape f ... Read More
-
Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025
“Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Recepto ... Read More
-
Endothelin Receptor Antagonist - Pipeline Insight, 2025
DelveInsight’s, “Endothelin Receptor Antagonist - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Endothelin Receptor Antagonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More
-
Autophagy modulators - Pipeline Insight, 2025
“Autophagy modulators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Autophagy modulators development. The report provides detailed coverage of the pipeline landscape for this mechan ... Read More
-
Apoptosis Inhibitor - Pipeline Insight, 2025
“Apoptosis Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apoptosis Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanis ... Read More
-
Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025
“Anti-Dickkopf-1 (Dkk-1) Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Dickkopf-1 (Dkk-1) Antibody development. The report provides detailed coverage of the pipeline l ... Read More
-
Anti-CD52 Antibody - Pipeline Insight, 2025
“Anti-CD52 Antibody - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-CD52 Antibody development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025
“Angiopoietin 2 (Ang-2) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiopoietin 2 (Ang-2) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More
-
Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025
“Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin II Receptor Type 2 (AT2 Receptor) Inhibitor development. The repor ... Read More
-
Alpha-1 Agonist - Pipeline Insight, 2025
“Alpha-1 Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1 Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of act ... Read More
-
Alpha Glucosidase Inhibitor - Pipeline Insight, 2025
“Alpha Glucosidase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha Glucosidase Inhibitor development. The report provides detailed coverage of the pipeline landscape f ... Read More
-
5-HT4 Partial Agonist - Pipeline Insight, 2025
“5-HT4 Partial Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Partial Agonist development. The report provides detailed coverage of the pipeline landscape for this mech ... Read More
-
5-HT2C Antagonist - Pipeline Insight, 2025
“5-HT2C Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT2B Antagonist - Pipeline Insight, 2025
“5-HT2B Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2B Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More
-
5-HT1A Antagonist - Pipeline Insight, 2025
“5-HT1A Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT1A Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of ... Read More